Gene Replacement and Gene Modifying Therapies: Therapeutics and Safety for Pharmacists

Launch Presentation (90 minutes)   Handout

With the approval of gene therapies in the United States, pharmacists need to be prepared to integrate these new treatments into practice. This educational activity begins with a discussion of the potential uses of gene therapies, as well as the scientific principles involved in their development and clinical application. Key considerations in assessing an organization’s readiness to provide gene therapy to patients, including risk management and safe handling in clinical practice, are also explored.

Agenda

Welcome and Introduction
John Petrich, B.S. Pharm., M.S.

Gene Therapy: Potential Application in Clinical Practice
Michael Storey, Pharm.D., M.S., BCPS

Science of Gene Therapy: An Overview
Michael Storey, Pharm.D., M.S., BCPS

Safe Handling of Gene Therapy and Organizational Readiness
John Petrich, B.S.Pharm., M.S.

Faculty Discussion and Audience Questions

Learning Objectives

  • Describe the potential application of gene therapy in cancer and rare diseases.
  • Explain the scientific principles involved in the development and clinical application of gene therapy.
  • Review key considerations in handling gene therapy products in all areas of the health system from a risk-management perspective.
  • Assess your organization’s readiness to provide gene therapy to patients through clinical trials and commercial therapy.

Like your favorites to provide us feedback!

Target Audience

This activity was planned to meet the educational needs of pharmacists in hospitals and health systems involved with investigational drugs, drug information, and formulary management.

Format

This online activity consists of slide presentations, active learning, and evaluation. View the system requirements.

 

Disclosures

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships. 

In this activity, only the individual/s below has disclosed a relevant financial relationship.  No other persons associated with this presentation have disclosed any relevant financial relationships.

Michael Storey, Pharm.D., M.S., BCPS

  • AveXis, Inc.: advisory board

Products that have not received FDA approval will be discussed during this presentation.

Claim CE Within 60 Days

Participants should claim CE credit for this home-study activity only if they have not claimed credit for the live activity.

To receive CE credit, complete the steps below within 60 days of completing the activity.

  1. View entire presentation and answer all polling questions.
  2. Click "Complete Activity" on the last slide to complete the assessment and evaluation.
  3. Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account. 

After the 60-day deadline, ASHP will no longer be able to report credit(s).

CPE Information

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE #: 0204-0000-18-443-H01-P
Release Date: March 1, 2019
Expiration Date: May 31, 2020
Activity Type: Application-based
CE Credits: 1.5 hours
Activity Fee: Free of charge